Kejun Nan

3k citations
59 papers · 2.2k · 1 hit paper · h-index 26

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
  • Hepatology top 5%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

Kejun Nan

59 papers receiving 2.2k citations

Kejun Nan's Hit Papers

Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer 2018 · 503 citations
5030+2+5Years since publication100200300400500

Peers

Kejun Nan
Comparison fields: 5 of 74
  • Cancer Research 448
  • Hepatology 262
  • Oncology 432
  • Pulmonary and Respiratory Medicine 386
  • Molecular Biology 633
Replace Josep M. Domingo Domenech with:
Josep M. Domingo Domenech United States
Meng Qiu China
Ray‐Hwang Yuan Taiwan
Yi‐Wu Dang China
Toshiya Ochiai Japan
Peiguo Cao China
Michihiko Wada Japan
Tomohiro Arita Japan
Huamei Tang China
Rong‐Quan He China
Kejun Nan relative to Josep M. Domingo Domenech United States Josep M. Domingo Domenech's profile →
Citations per field
00.5×1.5×1.9×
Josep M. Domingo Domenech · 1×
Citations per year

Countries citing papers authored by Kejun Nan

Since Specialization
Citations

This map shows the geographic impact of Kejun Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kejun Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kejun Nan more than expected).

Fields of papers citing papers by Kejun Nan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kejun Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kejun Nan. The network helps show where Kejun Nan may publish in the future.

Co-authors

The 25 scholars most cited alongside Kejun Nan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kejun Nan Line = papers co-authored together Kejun Nan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer
Hit paper breakdown →
2018503
2 2017219
3 2017139
4 201577
5 201760
6 201654
7 201752
8 201450
9 201848
10 201747
11 201847
12 201346
13 201344
14 201242
15 201737
16 201136
17 201636
18 201636
19 201735
20 201532

About Kejun Nan

Kejun Nan is a scholar working on Hepatology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 59 papers that have together received 2.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), MicroRNA in disease regulation (7 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer-related Molecular Pathways (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Gastric Cancer Management and Outcomes (3 papers), Cervical Cancer and HPV Research (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (448 citations), Hepatology (262 citations), Oncology (432 citations), Pulmonary and Respiratory Medicine (386 citations) and Molecular Biology (633 citations). Kejun Nan has collaborated with scholars based in China and United States. Frequent co-authors include Tao Tian, Hui Guo, Zhiping Ruan, Qiuping Liu, Shuhong Zhao, Mo‐qi Lv, Dang‐xia Zhou, Xuan Liang, Lili Jiang and Mincong Wang. Their work appears in journals such as Cancer Management and Research, Oncotarget, World Journal of Gastroenterology, Medicine and The International Journal of Biochemistry & Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact